SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001694665-23-000085
Filing Date
2023-06-12
Accepted
2023-06-12 16:05:16
Documents
2
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686600300.html 4  
1 FORM 4 wk-form4_1686600300.xml 4 3927
2 EX-24 evelo-section16poaxmcinnes.htm EX-24 8814
  Complete submission text file 0001694665-23-000085.txt   14118
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Issuer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE, SUITE 200 CAMBRIDGE MA 02139
Business Address
McInnes Iain B. (Reporting) CIK: 0001881757 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38473 | Film No.: 231008052